(Q34206213)

31 July 2017

1 reference

title

p53 functional assays: detecting p53 mutations in both the germline and in sporadic tumours (English)

1 reference

31 July 2017

R S Camplejohn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495849&resulttype=core&format=json

14 May 2020

J Rutherford

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495849&resulttype=core&format=json

14 May 2020

publication date

1 February 2001

1 reference

31 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495849&resulttype=core&format=json

14 May 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495849&resulttype=core&format=json

14 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495849&resulttype=core&format=json

14 May 2020

page(s)

1-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495849&resulttype=core&format=json

Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

P53, apoptosis, and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Abnormal expression of wild type p53 protein in normal cells of a cancer family patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Mechanisms of p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

The value of rapid functional assays of germline p53 status in LFS and LFL families

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Thymocyte apoptosis induced by p53-dependent and independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

A simple p53 functional assay for screening cell lines, blood, and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Identification of p53 as a sequence-specific DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Activation of p53 by oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

p53 is required for radiation-induced apoptosis in mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Comprehensive mutational scanning of the p53 coding region by two- dimensional gene scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.2001.00193.X

Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology

21 January 2018

1 reference

12 December 2020

Screening the p53 status of human cell lines using a yeast functional assay

1 reference

12 December 2020

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites

1 reference

12 December 2020

Sources of bias in the detection and reporting of p53 mutations in human cancer: analysis of the IARC p53 mutation database

1 reference

12 December 2020

Prognostic significance ofp53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assay

1 reference

12 December 2020

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

1 reference

12 December 2020

A cancer family syndrome in twenty-four kindreds

1 reference

12 December 2020

Simple identification of dominant p53 mutants by a yeast functional assay

1 reference

12 December 2020

Participation of p53 protein in the cellular response to DNA damage

1 reference

12 December 2020

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

12 December 2020

Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family

1 reference

12 December 2020

Overcoming Complexities in Genetic Screening for Cancer Susceptibility

1 reference

12 December 2020

Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast

1 reference

12 December 2020

p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis

1 reference

12 December 2020

p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.

1 reference

12 December 2020

p53 and human cancer: the first ten thousand mutations.

1 reference

12 December 2020

Characterization of p53 mutants identified in human tumors with a missense mutation in the tetramerization domain

1 reference

12 December 2020

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53

1 reference

12 December 2020

DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies

1 reference

12 December 2020

p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.

1 reference

12 December 2020

p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry

1 reference

12 December 2020

Screening patients for heterozygous p53 mutations using a functional assay in yeast

1 reference

12 December 2020

10.1046/J.1365-2184.2001.00193.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495849&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6495849&resulttype=core&format=json

14 May 2020

11284915

1 reference